BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
36 hedge funds and large institutions have $8.69M invested in BRAINSTORM CELL THERAPUTC in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
3% less funds holding
Funds holding: 37 → 36 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
50% less call options, than puts
Call options by funds: $7K | Put options by funds: $14K
Holders
36
Holding in Top 10
1
Calls
$7K
Puts
$14K
Top Buyers
| 1 | +$368K | |
| 2 | +$172K | |
| 3 | +$102K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$36K |
Top Sellers
| 1 | -$395K | |
| 2 | -$47K | |
| 3 | -$34.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
-$23K |